Weight loss isn't the only change Individuals who are taking a GLP-1 weight loss medicine are seeing. They also tend to spend ...

US price cuts, Medicare expansion, and new oral GLP-1 approvals reshape the competitive outlook for weight-loss drugs.

Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

Families using GLP-1s are spending less on food, from grocery stores to restaurants, according to a study published Dec. 18 ...

From there, a licensed provider reviews your responses and makes a personal recommendation, which could include a GLP-1 ...

Fox News senior medical analyst Dr. Marc Siegel joins 'America's Newsroom' to discuss the approval of a GLP-1 pill for weight loss and compares it to injection-based alternatives.

Both Novo Nordisk’s and competitor Eli Lilly’s injectable GLP-1 drugs, Wegovy and Zepbound, have helped transform obesity ...

Chronic pain teaches you to gamble with yourself. There’s always one more treatment, one more possible cure, one more ...

At the end of the day, GLP-1s can be a powerful tool for achieving your weight loss goals, but only if they're safe and ...

Expert Dr. Salas-Whalen reveals that body composition testing, not just the number on your scale, is key to knowing whether ...

There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...

The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...